nach oben

Quality of Life Research

Erschienen in:

01.07.2015

The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients

verfasst von: Chen-Wei Pan, Hong-Peng Sun, Xingzhi Wang, Qinghua Ma, Yong Xu, Nan Luo, Pei Wang

Erschienen in: Quality of Life Research | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the discriminative power of the index scores of EQ-5D-5L (5L) and EQ-5D-3L (3L) in diabetes patients in China.

Methods

A consecutive sample of type 2 diabetes mellitus (T2DM) patients in the clinics self-completed the two versions of EQ-5D. The 3L index score was obtained from the Chinese 3L value set; the 5L index score was predicted from the 3L index score using an interim scoring. Relative efficiency (RE) of the 5L and 3L index scores was calculated to compare their ability in differentiating between T2DM patients with and without one of ten clinical conditions. The efficiency of the 5L and 3L health state classification systems was assessed using the Shannon index (H′) and in terms of ceiling effects.

Results

A total of 289 T2DM patients participated in this study. The 5L score was systematically lower than the 3L score for T2DM patients with and without a condition (range −0.36 to −0.06). The 5L score exhibited higher discriminative power in nine of ten conditions, with the mean RE value being 1.92. 5L had higher H′ values than 3L in all the five EQ-5D dimensions: mobility (1.14 vs. 0.70), self-care (0.44 vs. 0.33), usual activities (0.72 vs. 0.47), pain/discomfort (1.58 vs. 1.10), and anxiety/depression (1.03 vs. 0.67). The overall ceiling effects decreased from 56.7 % (3L) to 36.7 % (5L).

Conclusion

The 5L index score is more discriminative than the 3L index score in T2DM patients and therefore is preferable for use in this population.

Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33, 337–343.PubMedCrossRef

Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35, 1095–1108.PubMedCrossRef

Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 45, 203–220.CrossRef

Liu, G., Wu, H., Li, M., Gao, C., & Luo, N. (2014). Chinese time trade-off values for EQ-5D health states. Value in Health, 17, 597–604.PubMedCrossRef

Luo, N., Wang, P., Thumboo, J., Lim, Y. W., & Vrijhoef, H. J. (2014). Valuation of EQ-5D-3L health states in Singapore: Modeling of time trade-off values for 80 empirically observed health states. Pharmacoeconomics, 30(5), 495–507.CrossRef

Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., et al. (2002). Estimating an EQ-5D population value set: The case of Japan. Health Economics, 11(4), 341–353.PubMedCrossRef

Baida, X., Roset, M., Herdman, M., & Kind, P. (2001). A comparison of United Kingdom and Spanish general population general population time trade-off values for EQ-5D health states. Medical Decision Making, 21(1), 7–16.CrossRef

Luo, N., Johnson, J. A., Shaw, J. W., & Coons, S. J. (2007). A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions. Medical Decision Making, 27(3), 321–326.CrossRef

Norman, R., Cronin, P., Viney, R., King, M., Street, D., & Ratcliffe, J. (2009). International comparisons in valuing EQ-5D health states: A review and analysis. Value in Health, 12(8), 1194–1200.PubMedCrossRef

10.

Janssen, M. F., Lubetkin, E. I., Sekhobo, J. P., & Pickard, A. S. (2011). The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabetic Medicine, 28, 395–413.PubMedCrossRef

11.

Wang, H. M., Patrick, D. L., Edwards, T. C., Skalicky, A. M., Zeng, H. Y., & GU, W. W. (2012). Validation of the EQ-5D in a general population sample in urban China. Quality of Life Research, 21(1), 155–160.PubMedCrossRef

12.

Luo, N., Cang, S. Q., Quan, H. M. J., How, C. H., & Tay, E. G. (2012). The discriminative power of the EuroQol visual analog scale is sensitive to survey language in Singapore. Health and Quality of Life Outcomes, 10, 32.PubMedCentralPubMedCrossRef

13.

Pickard, A. S., Wilke, C. T., Lin, H. W., et al. (2007). Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics, 25, 365–394.PubMedCrossRef

14.

Ong, S. C., Mark, B., Aung, M. O., Li, S. C., & Lim, S. G. (2008). Health-related quality of life in chronic hepatitis B patients. Hepatology, 47(4), 1108–1117.PubMedCrossRef

15.

McLernon, D. J., Dillon, J., & Donna, P. T. (2008). Health-state utilities in liver disease: A systematic review. Medical Decision Making, 28(4), 582–592.PubMedCrossRef

16.

Macran, S., Weatherly, H., & Kind, P. (2003). Measuring population health? A comparison of three generic health status measures. Medical Care, 42, 218–231.

17.

Petrou, S., & Hockely, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14, 1169–1189.PubMedCrossRef

18.

Myers, C., & Wilks, D. (1999). Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Quality of Life Research, 8, 9–16.PubMedCrossRef

19.

Bharmal, M., & Thomas, J. I. I. I. (2006). Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value in Health, 9, 262–271.PubMedCrossRef

20.

Wang, H., Kindig, D. A., & Mullahy, J. (2005). Variation in Chinese population health related quality of life: Results from a EuroQol study in Beijing, China. Quality of Life Research, 14, 119–132.PubMedCrossRef

21.

Brazier, J., Roberts, J., & Tsychiya, A. (2004). A comparison of the EQ-5D and SF-6D across seven patients groups. Health Economics, 13, 873–884.PubMedCrossRef

22.

Bech, P., Moses, R., & Gomis, R. (2008). The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: A placebo-controlled, multicentre study. Quality of Life Research, 12, 413–425.CrossRef

23.

Bagust, A., & Beale, S. (2005). Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Economics, 14, 217–230.PubMedCrossRef

24.

Morgan, C. L., McEwan, P., Morrissey, M., Peter, J. R., Poole, C., & Currie, C. J. (2006). Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications. Diabetic Medicine, 23, 1100–1105.PubMedCrossRef

25.

EuroQol Group. EQ-5D-5L User Guide. (2014). Basic information on how to use the EQ-5D-5L instrument. http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Folders_Flyers/UserGuide_EQ-5D-5L.pdf. Accessed 10 July 2014.

26.

van Hout, B., Janssen, M. F., Feng, Y. S., Kohlmann, T., Busschbach, J., Golicki, D., et al. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health, 15(5), 708–715.PubMedCrossRef

27.

Jia, Y. X., Cui, F. Q., Li, L., Zhang, D. L., Zhang, G. M., Wang, F. Z., et al. (2014). Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Quality of Life Research,. doi:10.1007/311136-014-0670-3.PubMed

28.

Kim, S. H., Kim, H. J., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21(6), 1065–1073.PubMedCrossRef

29.

Pickard, A. S., De leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care, 45(3), 259–263.PubMedCrossRef

30.

Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic disease. Quality of Life Research, 22(7), 1707–1716.PubMedCrossRef

31.

Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727.PubMedCentralPubMedCrossRef

32.

Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value in Health, 11(2), 275–284.PubMedCrossRef

33.

Craig, B. M., Pickard, A. S., & Lubetkin, E. I. (2014). Health problems are more common, but less severe when measured using newer EQ-5D versions. Journal of Clinical Epidemiology, 67, 93–99.PubMedCentralPubMedCrossRef

34.

Shannon, C. E., & Weaver, W. (1948). A mathematical theory of communication. Bell System Technical Journal, 27, 161–163.CrossRef

35.

Janssen, M. F., Birnie, E., & Bonsel, G. J. (2007). Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon’s indices. Quality of Life Research, 16(5), 895–904.PubMedCentralCrossRef

Titel: The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients
verfasst von: Chen-Wei Pan
Hong-Peng Sun
Xingzhi Wang
Qinghua Ma
Yong Xu
Nan Luo
Pei Wang
Publikationsdatum: 01.07.2015
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 7/2015
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-014-0902-6

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2015

Health perceptions and symptom burden in primary care: measuring health using audio computer-assisted self-interviews

Perceptions of QOL among caregivers of Mexican ancestry of adults with advanced cancer

Mapping the disease-specific LupusQoL to the SF-6D

Erratum to: Genetic variations underlying self-reported physical functioning: a review

Training clinicians in how to use patient-reported outcome measures in routine clinical practice

The impact of social support at home on health-related quality of life among veterans with spinal cord injury participating in a supported employment program